The incidence and magnitude of fibrinolytic activation in trauma patients: a rebuttal
- PMID: 23593973
- PMCID: PMC4074078
- DOI: 10.1111/jth.12240
The incidence and magnitude of fibrinolytic activation in trauma patients: a rebuttal
Conflict of interest statement
The authors state that they have no conflict of interest.
Comment in
-
The incidence and magnitude of fibrinolytic activation in trauma patients: a reply to a rebuttal.J Thromb Haemost. 2013 Jul;11(7):1437-8. doi: 10.1111/jth.12296. J Thromb Haemost. 2013. PMID: 23663357 No abstract available.
Comment on
-
The incidence and magnitude of fibrinolytic activation in trauma patients.J Thromb Haemost. 2013 Feb;11(2):307-14. doi: 10.1111/jth.12078. J Thromb Haemost. 2013. PMID: 23176206
References
-
- Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38:185–93. - PubMed
-
- Floccard B, Rugeri L, Faure A, Saint Denis M, Boyle EM, Peguet O, Levrat A, Guillame C, Marcotte G, Vulliez A, Hautin E, David JS, Negrier C, Allaouchiche B. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury. 2012;43:26–32. - PubMed
-
- CRASH-2 Trial Collaborators 2010. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376:23–32. - PubMed
-
- Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De’ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, Maccallum PK, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013;11:307–14. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical